Stonehaven Incubate is a pioneering company focused on translating disruptive human healthcare technologies into the animal health sector. The company collaborates with innovators to build standalone animal health companies, targeting both companion and production animals. Operating in the rapidly growing animal health market, which is expected to reach $78 billion by 2021 with a CAGR of 5.4%, Stonehaven Incubate serves clients ranging from pet owners to farmers. The business model revolves around identifying unique opportunities in human health innovations and applying them to animal health, thereby creating new commercial ventures. Revenue is generated through the development and commercialization of these innovative solutions, which include microbiome science and therapeutic platforms. The company benefits from high profit margins, favorable R&D cycles, and long product life cycles in the animal health industry. Key drivers include increasing pet ownership, improving standards of care, and the digitization of health in the companion animal sector, as well as rising protein demand and safer, antibiotic-free foods in the production animal sector.

Keywords: animal health, human healthcare technologies, microbiome science, companion animals, production animals, innovation, commercialization, pet ownership, protein demand, digitization.